In conclusion, we demonstrated that mogroside IVe has the ability to suppress the proliferation of colorectal cancer and throat cancer cells by inducing apoptosis through upregulation of p53, and downregulation of p-ERK1/2 and MMP-9 levels, strongly indicating anticancer activity. Here, MMP9 is linked to colorectal cancer.